Evaluation of Centralised TB Assay Solutions
Conditions:   Tuberculosis;   Drug-resistant Tuberculosis Intervention:   Sponsor:   Foundation for Innovative New Diagnostics, Switzerland Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 1, 2019 Category: Research Source Type: clinical trials

Atorvastatin to Reduce Inflammation After Tuberculosis Treatment Completion
Condition:   Tuberculosis, Pulmonary Interventions:   Drug: Atorvastatin 40mg;   Drug: Placebo oral tablet Sponsors:   University of Cape Town;   University of Zurich;   University of Namibia;   University of Bern;   University of Stellenbosch Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 1, 2019 Category: Research Source Type: clinical trials

Evaluation of Centralised TB Assay Solutions
Conditions:   Tuberculosis;   Drug-resistant Tuberculosis Intervention:   Sponsor:   Foundation for Innovative New Diagnostics, Switzerland Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 1, 2019 Category: Research Source Type: clinical trials

Evaluation of Immune Cell Markers in Diagnosis of Tuberculosis
Condition:   Tuberculosis Infection Intervention:   Diagnostic Test: TB-antigen responsive T cell markers Sponsor:   Tongji University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 1, 2019 Category: Research Source Type: clinical trials

Intensified Tuberculosis Treatment to Reduce the Mortality of Patients With Tuberculous Meningitis
Condition:   Tuberculous Meningitis Interventions:   Drug: Aspirin;   Drug: Placebo of aspirin;   Drug: WHO TBM treatment;   Drug: Intensified TBM treatment Sponsors:   French National Institute for Health and Medical Research-French National Agency for Research on AIDS and Viral Hepatitis (Inserm-ANRS);   European Union;   European and Developing Countries Clinical Trials Partnership (EDCTP) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 30, 2019 Category: Research Source Type: clinical trials

Clinical Concordance Evaluation of T-SPOT ®.TB Assay Performance (T-Cell SelectTM Study)
Condition:   Tuberculosis Intervention:   Diagnostic Test: T-Cell SelectTM Kit Sponsor:   Oxford Immunotec Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 28, 2019 Category: Research Source Type: clinical trials

Clinical Concordance Evaluation of T-SPOT ®.TB Assay Performance (T-Cell SelectTM Study)
Condition:   Tuberculosis Intervention:   Diagnostic Test: T-Cell SelectTM Kit Sponsor:   Oxford Immunotec Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 28, 2019 Category: Research Source Type: clinical trials

DOT Selfie: A Mobile Technology Intervention to Evaluate Treatment Adherence Among Tuberculosis Patients
Condition:   Tuberculosis Interventions:   Device: DOT Selfie Intervention;   Other: In-person DOT Sponsors:   University of Georgia;   Makerere University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 22, 2019 Category: Research Source Type: clinical trials

POC Strategies to Improve TB Care in Advanced HIV Disease
Conditions:   Extrapulmonary Tuberculosis;   Tuberculosis, Pulmonary;   Human Immunodeficiency Virus (HIV);   Acquired Immunodeficiency Syndrome Intervention:   Diagnostic Test: LF-LAM Sponsors:   University of Southern Denmark;   Odense University Hospital;   National Tuberculosis Control Programme, Ghana;   Odense Patient Data Explorative Network;   University of Ghana;   Tema General Hospital, Ghana;   Lekma Hospital, ...
Source: ClinicalTrials.gov - October 10, 2019 Category: Research Source Type: clinical trials

ChAdOx1 85A Aerosol Versus Intramuscular Vaccination in Healthy Adults (TB039)
Conditions:   Mycobacterium Tuberculosis, Protection Against;   Tuberculosis Interventions:   Biological: ChadOx1 85A - aerosol;   Biological: ChadOx1 85A - IM Sponsors:   François Spertini;   University of Oxford Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 10, 2019 Category: Research Source Type: clinical trials

POC Strategies to Improve TB Care in Advanced HIV Disease
Conditions:   Extrapulmonary Tuberculosis;   Tuberculosis, Pulmonary;   Human Immunodeficiency Virus (HIV);   Acquired Immunodeficiency Syndrome Intervention:   Diagnostic Test: LF-LAM Sponsors:   University of Southern Denmark;   Odense University Hospital;   National Tuberculosis Control Programme, Ghana;   Odense Patient Data Explorative Network;   University of Ghana;   Tema General Hospital, Ghana;   Lekma Hospital, ...
Source: ClinicalTrials.gov - October 10, 2019 Category: Research Source Type: clinical trials

ChAdOx1 85A Aerosol Versus Intramuscular Vaccination in Healthy Adults (TB039)
Conditions:   Mycobacterium Tuberculosis, Protection Against;   Tuberculosis Interventions:   Biological: ChadOx1 85A - aerosol;   Biological: ChadOx1 85A - IM Sponsors:   François Spertini;   University of Oxford Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 10, 2019 Category: Research Source Type: clinical trials

POC Strategies to Improve TB Care in Advanced HIV Disease
Conditions:   Extrapulmonary Tuberculosis;   Tuberculosis, Pulmonary;   Human Immunodeficiency Virus (HIV);   Acquired Immunodeficiency Syndrome Intervention:   Diagnostic Test: LF-LAM Sponsors:   University of Southern Denmark;   Odense University Hospital;   National Tuberculosis Control Programme, Ghana;   Odense Patient Data Explorative Network;   University of Ghana;   Tema General Hospital, Ghana;   Lekma Hospital, ...
Source: ClinicalTrials.gov - October 10, 2019 Category: Research Source Type: clinical trials

ChAdOx1 85A Aerosol Versus Intramuscular Vaccination in Healthy Adults (TB039)
Conditions:   Mycobacterium Tuberculosis, Protection Against;   Tuberculosis Interventions:   Biological: ChadOx1 85A - aerosol;   Biological: ChadOx1 85A - IM Sponsors:   François Spertini;   University of Oxford Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 10, 2019 Category: Research Source Type: clinical trials

POC Strategies to Improve TB Care in Advanced HIV Disease
Conditions:   Extrapulmonary Tuberculosis;   Tuberculosis, Pulmonary;   Human Immunodeficiency Virus (HIV);   Acquired Immunodeficiency Syndrome Intervention:   Diagnostic Test: LF-LAM Sponsors:   University of Southern Denmark;   Odense University Hospital;   National Tuberculosis Control Programme, Ghana;   Odense Patient Data Explorative Network;   University of Ghana;   Tema General Hospital, Ghana;   Lekma Hospital, ...
Source: ClinicalTrials.gov - October 10, 2019 Category: Research Source Type: clinical trials

ChAdOx1 85A Aerosol Versus Intramuscular Vaccination in Healthy Adults (TB039)
Conditions:   Mycobacterium Tuberculosis, Protection Against;   Tuberculosis Interventions:   Biological: ChadOx1 85A - aerosol;   Biological: ChadOx1 85A - IM Sponsors:   François Spertini;   University of Oxford Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 10, 2019 Category: Research Source Type: clinical trials

POC Strategies to Improve TB Care in Advanced HIV Disease
Conditions:   Extrapulmonary Tuberculosis;   Tuberculosis, Pulmonary;   Human Immunodeficiency Virus (HIV);   Acquired Immunodeficiency Syndrome Intervention:   Diagnostic Test: LF-LAM Sponsors:   University of Southern Denmark;   Odense University Hospital;   National Tuberculosis Control Programme, Ghana;   Odense Patient Data Explorative Network;   University of Ghana;   Tema General Hospital, Ghana;   Lekma Hospital, ...
Source: ClinicalTrials.gov - October 10, 2019 Category: Research Source Type: clinical trials

ChAdOx1 85A Aerosol Versus Intramuscular Vaccination in Healthy Adults (TB039)
Conditions:   Mycobacterium Tuberculosis, Protection Against;   Tuberculosis Interventions:   Biological: ChadOx1 85A - aerosol;   Biological: ChadOx1 85A - IM Sponsors:   François Spertini;   University of Oxford Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 10, 2019 Category: Research Source Type: clinical trials